These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21699581)

  • 21. Urinary nerve growth 53 factor correlates with the severity of urgency and pain: response to comments by Agilli et al.
    Kim SW; Jee SH; Moon SY; Kim JY; Kim JH
    Int Urogynecol J; 2015 Mar; 26(3):461. PubMed ID: 25335750
    [No Abstract]   [Full Text] [Related]  

  • 22. Urinary neurotrophic factors in healthy individuals and patients with overactive bladder.
    Antunes-Lopes T; Pinto R; Barros SC; Botelho F; Silva CM; Cruz CD; Cruz F
    J Urol; 2013 Jan; 189(1):359-65. PubMed ID: 23174241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker.
    Oktar T; Kocak T; Oner-Iyidogan Y; Erdem S; Seyithanoglu M; Ziylan O; Kocak H
    J Pediatr Urol; 2013 Oct; 9(5):617-21. PubMed ID: 22789557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of eviprostat on bladder overactivity in an experimental cystitis rat model.
    Kobayashi M; Nomura M; Nishii H; Matsumoto S; Fujimoto N; Matsumoto T
    Int J Urol; 2008 Apr; 15(4):356-60. PubMed ID: 18380828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary nerve growth factor and a variable solifenacin dosage in patients with an overactive bladder.
    Ciftci S; Ozkurkcugil C; Yilmaz H; Ustuner M; Yavuz U; Yuksekkaya M; Cekmen MB
    Int Urogynecol J; 2016 Feb; 27(2):275-80. PubMed ID: 26310546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis.
    Qu HC; Yan S; Zhang XL; Zhu XW; Liu YL; Wang P
    Genet Mol Res; 2014 Apr; 13(4):8609-19. PubMed ID: 24782215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction.
    Vizzard MA
    Exp Neurol; 2000 Jan; 161(1):273-84. PubMed ID: 10683293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis models.
    Oyama T; Homan T; Kyotani J; Oka M
    Eur J Pharmacol; 2012 Feb; 676(1-3):75-80. PubMed ID: 22197002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A potential biomarker for objective diagnosis of overactive bladder: urinary nerve growth factor.
    Agilli M; Aydin FN; Kurt YG; Cayci T
    Int Urol Nephrol; 2015 Feb; 47(2):317-8. PubMed ID: 25425438
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.
    Liu HT; Kuo HC
    J Urol; 2008 Jun; 179(6):2270-4. PubMed ID: 18423678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overactive bladder changes with time: a 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels.
    Chuang FC; Liu HT; Wang LY; Kuo HC
    J Urol; 2014 Aug; 192(2):458-63. PubMed ID: 24594404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebuttal comments on "a potential biomarker for objective diagnosis of overactive bladder: urinary nerve growth factor".
    Hai B
    Int Urol Nephrol; 2015 Feb; 47(2):319. PubMed ID: 25532476
    [No Abstract]   [Full Text] [Related]  

  • 33. Urinary nerve growth factor in children with overactive bladder: a promising, noninvasive and objective biomarker?
    Ergin G; Ebiloglu T; Kibar Y; Kopru B
    J Pediatr Urol; 2014 Oct; 10(5):976. PubMed ID: 25104420
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravesical hyaluronic acid treatment improves bacterial cystitis and reduces cystitis-induced hypercontractility in rats.
    Yıldız N; Alpay H; Tuğtepe H; Özdemir Kumral ZN; Akakın D; İlki A; Şener G; Ç Yeğen B
    Int J Urol; 2015 Jun; 22(6):598-603. PubMed ID: 25808602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.
    Chung SD; Liu HT; Lin H; Kuo HC
    Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intrathecal administration of E-series prostaglandin 1 receptor antagonist in a cyclophosphamide-induced cystitis rat model.
    Wada N; Matsumoto S; Kita M; Watanabe M; Hashizume K; Kakizaki H
    Int J Urol; 2013 Feb; 20(2):235-40. PubMed ID: 22925406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vitamin D analog on bladder function and sensory signaling in animal models of cystitis.
    Shapiro B; Redman TL; Zvara P
    Urology; 2013 Feb; 81(2):466.e1-7. PubMed ID: 23374845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial comment to interleukin-6 levels in female rats with protamine sulfate-induced chronic cystitis treated with hyaluronic acid.
    Saito M
    Int J Urol; 2013 Oct; 20(10):1023. PubMed ID: 23360376
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT; Chancellor MB; Kuo HC
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of urinary nerve growth factor for the diagnosis and assessment of the biofeedback success in children with dysfunctional voiding.
    Ergin G; Kibar Y; Ebiloğlu T; Irkılata HC; Kopru B; Kaya E; Uyanık M; Tapan S; Dayanc MM
    J Pediatr Urol; 2016 Apr; 12(2):118.e1-6. PubMed ID: 26701107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.